Effect of IL-15 addition on asbestos-induced suppression of human cytotoxic T lymphocyte induction

Naoko Kumagai-Takei1, Yasumitsu Nishimura2, Hidenori Matsuzaki1,3

  • 1Department of Hygiene, Kawasaki Medical School, Kurashiki, 701-0192, Japan.

Abstract

Insights

Interleukin-15 (IL-15) partially restores antitumor immunity suppressed by asbestos exposure. IL-15 aids in recovering cytotoxic T lymphocyte (CTL) proliferation and function, offering a potential therapeutic avenue against asbestos-induced immune dysfunction.

Area of Science:

  • Immunology
  • Environmental Health
  • Toxicology

Background:

  • Asbestos fibers are linked to mesothelioma and suppress antitumor immunity.
  • Asbestos exposure reduces cytotoxic T lymphocyte (CTL) induction and CD8+ T cell proliferation.
  • Interleukin-2 (IL-2) does not fully explain asbestos-induced CTL suppression.

Purpose of the Study:

  • Investigate the role of interleukin-15 (IL-15) in asbestos-induced suppression of CTL differentiation.
  • Determine if IL-15 can restore immune function impaired by asbestos exposure.

Main Methods:

  • Mixed lymphocyte reaction (MLR) with human peripheral blood mononuclear cells (PBMCs) exposed to chrysotile B asbestos.
  • Addition of IL-15 during MLR to assess its impact on CD8+ T cell markers.
  • Flow cytometry analysis of T cell proliferation, activation, and cytotoxic markers (e.g., granzyme B).

Main Results:

  • IL-15 partially reversed the reduction in CD3+CD8+ T cell numbers caused by asbestos.
  • IL-15 fully restored the percentage of granzyme B-positive cells in CD8+ T cells, including both proliferating and non-proliferating populations.
  • IL-15 did not reverse the decrease in CD25+ and CD45RO+ cells on CD8+ T lymphocytes.

Conclusions:

  • Asbestos-induced CTLs exhibit dysfunction that IL-15 can partially compensate.
  • IL-15 is more effective than IL-2 in recovering proliferation and granzyme B levels in asbestos-suppressed CTL induction.